SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as crude prices climb amid reported Middle East shipping and energy-infrastructure attacks, fueling concerns about supply disruptions. Traders are divided between expecting the supply-risk rally to continue and anticipating a pullback if tensions ease; some also caution that the expiring WTI contract can distort comparisons with the next contract.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is under pressure after HSBC warned that heavy borrowing needs and potentially slower AI-compute demand could challenge its growth and returns, sharpening traders concerns about debt, refinancing, and dilution amid a broader neocloud selloff. Bears warn of credit and business-model risks, while bulls point to contracted demand and continued AI infrastructure growth; some also cite Goldman Sachss more positive view and ARKs share purchases.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras shares have slid to post-IPO lows amid concern over insider selling and successive lockup share releases, with traders also pointing to a TD Cowen price-target cut and questions about growth, scaling, and reliance on OpenAI. The discussion is sharply divided between calls for more downside and buyers arguing the selloff is overdone and the AI-chip technology has long-term potential.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale shares are under pressure after UBS downgraded the stock, citing long commercialization timelines and limited firm customer commitments, with uncertainty around the proposed TVA deployment adding to execution concerns. Traders are split between viewing the selloff as an overreaction and seeing it as confirmation of risks facing NuScale and the broader nuclear sector.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A tech-led rebound after the recent selloff, ahead of major megacap earnings, is driving QQQ discussion. Traders are divided over whether it marks a durable recovery or a relief rally that could fade, with AI investment and debt concerns and surging oil prices adding to caution.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GE Aerospaces third-quarter earnings beat and raised 2026 guidance are driving attention, with traders also citing stronger orders. Many view the report as bullish, while others are cautious about whether the stock can hold its post-earnings strength amid muted or weakening price action.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GMs quarterly earnings and revenue beat estimates, but traders are focused on the tightened full-year profit outlook rather than a larger guidance increase. The new buyback program is a positive offset for some, while others question why shares are falling despite the beat.

Northrop Grumman Corp. engages in the provision of advanced aircraft systems. It operates through the following segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The Aeronautics Systems segment is involved in the design, development, production, integration, sustainment, and modernization of advanced aircraft systems for the U.S. Air Force, the U.S. Navy, other U.S. government agencies, and international customers. The Defense Systems segment includes integrated battle management systems, weapons systems and aircraft, and mission systems sustainment and modernization. The Mission Systems segment offers advanced mission solutions and multifunction systems, primarily for the U.S. defense and intelligence community, and international customers. The Space Systems segment delivers end-to-end mission solutions through the design, development, integration, production and operation of space, missile defense, launch and strategic missile systems for national security, civil government, commercial, and international customers. The company was founded by John K. Northrop, Thomas V. Jones, and Kent Kresa in 1939 and is headquartered in Falls Church, VA.

Northrop Grumman Corp.

Northrops Q3 results beat expectations and management raised its full-year outlook, with a record backlog reinforcing the growth case. Traders are debating why shares remain under pressure despite the strong report, pointing to margin and cash-flow concerns and the possibility that the positive news was already priced in.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples iPhone Duo preorders reportedly sold out quickly, with deliveries pushed out, drawing bullish attention to demand and the stocks resilience while AI and semiconductor shares faced pressure. Skeptics counter that limited launch supply may explain the sellout and question whether the premium-priced phone will drive meaningful incremental sales, amid broader concerns about Apples valuation.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius has been caught in a sharp neocloud and AI-infrastructure selloff as traders debate whether heavy buildout spending can earn adequate returns and whether financing risksespecially at CoreWeavewill spread across the sector. The community is split between treating the rebound after the decline as an oversold bounce and expecting more downside, while some argue Nebius is better positioned than debt-heavier peers and that compute demand remains strong.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit

DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud LawsuitPR NewswireNEW YORK, Oct. 17, 2026 NEW YORK, Oct. 17, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds...

Why Doximity (DOCS) Dipped More Than Broader Market Today

Doximity (DOCS) closed the most recent trading day at $30.71, moving 2.51% from the previous trading session.

DOCS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before November 16, 2026 Deadline

DOCS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before November 16, 2026 Deadline DOCS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Doximity, Inc. Investors with...

Doximity to Release Fiscal 2027 Second Quarter Results on November 5, 2026

Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ended September 30, 2026 after market close on November 5, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT...

Doximity Deepens U.S. News Alliance to Improve Patient Access to Care

DOCS extends its 13-year partnership with U.S. News, strengthening its role in physician searches, appointment booking and hospital rankings.

DOCS Shareholder Alert: Doximity, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt

DOCS Shareholder Alert: Doximity, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt DOCS Shareholder Alert: Doximity, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallStPR NewswireNEW YORK, Oct. 15, 2026Doximity co-founder and former Chief Strategy...

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines - DOCS

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines - DOCS INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming...

DOCS Stockholders Have Rights - If you Lost Money Investing in Doximity, Inc. Contact Robbins LLP for Information About Recovering Your Losses

DOCS Stockholders Have Rights - If you Lost Money Investing in Doximity, Inc. Contact Robbins LLP for Information About Recovering Your Losses DOCS Stockholders Have Rights - If you Lost Money Investing in Doximity, Inc. Contact Robbins LLP for Information About Recovering Your LossesPR NewswireSAN...

DOCS DEADLINE: Levi & Korsinsky Reminds Doximity, Inc. Investors of Upcoming Securities Class Action Deadline

DOCS DEADLINE: Levi & Korsinsky Reminds Doximity, Inc. Investors of Upcoming Securities Class Action Deadline DOCS DEADLINE: Levi & Korsinsky Reminds Doximity, Inc. Investors of Upcoming Securities Class Action DeadlinePR NewswireNEW YORK, Oct. 14, 2026Doximity's CEO and former CFO are named as...

Doximity, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DOCS

Doximity, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DOCS Doximity, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DOCSPR NewswireNEW YORK, Oct. 13, 2026NEW YORK, Oct. 13, 2026/PRNewswire/ -- The DJS Law...

Doximity, Inc. engages in the development and operation of an online platform for medical professionals. Its cloud-based software has the ability to enable users to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. The company was founded by Shari Buck, Konstantin Guericke, Nate Gross, and Jeffrey A. Tangney on April 16, 2010 and is headquartered in San Francisco, CA.

Doximity Inc - Ordinary Shares - Class A

DOCS Stock Soars After CEO Says Clinical AI Outperformed Anthropic, Wall Street Lifts Price Targets 

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>CEO Jeff Tangney attributed Doximity’s performance over Anthropic to proprietary medical data and physician oversight.</li><li>Canaccord and BMO Capital raised their price targets on Doximity, citing growing demand for the company's AI products.</li><li>Canaccord forecast that AI revenue would become a meaningful growth driver in the third quarter.</li></ul>Shares of Doximity (DOCS) surged as much as over 200% in pre-market trade on Friday before paring most of the gains despite an earnings miss after CEO Jeff Tangney touted the company’s growing artificial intelligence capabilities and said that its clinical AI outperformed Anthropic's latest model in physician-focused testing.&nbsp;During the earnings call, Chief Executive Jeff Tangney said Doximity's clinical AI recorded a 4.8% error rate, compared with 13.6% for what he called Anthropic's “best model”, Fable 5.Canaccord also raised its price target on DOCS stock to $36 from $30 and kept a ‘Buy’ rating on the shares, citing growing demand for Doximity's AI products, especially from pharmaceutical companies. Meanwhile, BMO Capital raised its price target to $30 from $20 and kept a ‘Market Perform’ rating on the shares.&nbsp;DOCS stock more than tripled at one point in pre-market trading before the rally cooled to about 100%, putting the shares on track to hit a six-month high. The stock was among the top trending tickers on Stocktwits, and on track to hit highs not seen since January.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/DOCS_2026_08_07_07_30_17_c573acda34.png" alt="DOCS_2026-08-07_07-30-17.png" width="2643" height="1588"><figcaption>DOCS stock’s performance year-to-date. | Source: TradingView</figcaption></figure>If the gains hold above 40%, the rally would mark the biggest single-day gain in the stock's history, surpassing the previous record of 38.74% set in August 2024.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20260807_072949232_ff7ee6d5f9.png" alt="koyfin_20260807_072949232.png" width="2400" height="1240"><figcaption>DOCS stock’s historical single-day gains. | Source: Koyfin</figcaption></figure><h2 class="st-heading-2">Doximity Says Its AI Outperformed Anthropic</h2>Tangney said Doximity’s performance advantage over Anthropic stemmed from two key differentiators. The first is a built-in, expert-verified drug reference system designed to improve dosing accuracy and drug interaction checks. The other is a network of more than 12,000 physician "PeerCheck" editors who continuously review and refine the platform's AI-generated responses."We're proving you can still post best-in-class software margins while investing heavily in clinical AI," Tangney said. "We're leaning in because we see a once-in-a-generation opportunity to build the new AI age of medicine."He added that AI represents "the next chapter" in Doximity's growth strategy, building on its position as a digital platform for physicians.<h2 class="st-heading-2">Canaccord Sees AI Becoming A Major Growth Driver</h2>The brokerage said AI revenue has yet to materially contribute to Doximity's financial results but is already generating meaningful customer interest.&nbsp;Analysts pointed to growing demand from pharmaceutical companies for Doximity's AI tools, particularly search marketing capabilities within its "Ask" platform, which they said is driving engagement with clients.Canaccord expects meaningful AI monetization to begin in the third quarter, with the segment becoming an increasingly important contributor to the company's long-term growth.BMO Capital echoed the view, stating AI Search traction and increased AI utilization support long-term monetization. However, the firm added that near-term margin pressure from higher compute costs may weigh on the balance sheet.<h2 class="st-heading-2">How Is Retail Feeling About DOCS Stock?</h2>On Stocktwits, retail sentiment around DOCS stock improved to ‘extremely bullish’ from ‘bullish’ over the past day, while chatter rose to ‘extremely high’ from ‘high’ levels.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_08_07_070424_1_03bfe0a28d.png" alt="Screenshot 2026-08-07 070424 (1).png" width="1274" height="684"><figcaption>DOCS stock retail sentiment on August 7 as of 7:45 a.m. ET | Source: Stocktwits</figcaption></figure>Many retail traders on the platform warned that the rally in DOCS might be a short squeeze in the making.<stembedurl>https://www.stocktwits.com/Iorgi/message/661226224</stembedurl><stembedurl>https://www.stocktwits.com/AsymmetricUpsideEnjoyer/message/661231790</stembedurl>Not accounting for the pre-market rally, DOCS stock has dropped more than 50% this year and nearly 65% in the last 12 months.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/soun-stock-hits-2-month-high-biggest-single-day-gain-price-target-cuts/cZoBcXZRJJE">SOUN Stock Hits 2-Month High, Rallying Toward Biggest Gain in 3 Months Despite Analyst Target Cuts</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Doximity, Inc. logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

CEO Jeff Tangney said Doximity's AI recorded a 4.8% error rate versus 13.6% for Anthropic's Fable 5.

DOCS Stock Soars After CEO Says Clinical AI Outperformed Anthropic, Wall Street Lifts Price Targets

CEO Jeff Tangney said Doximity's AI recorded a 4.8% error rate versus 13.6% for Anthropic's Fable 5.


Doximity Inc

iShares U.S. Healthcare Providers ETF

iShares Core S&P Mid-Cap ETF

Vanguard Health Care ETF

$DOCS

$AAOI

$CRSR

$TEAM

$DOCS, $AAOI, $CRSR, and $TEAM are all surging following their respective earnings reports. Which of these earnings declines are you most interested in buying? Vote and explain your reasoning in the comments.

Which of these earnings rallies are you most interested in buying - $DOCS, $AAOI, $CRSR, or $TEAM?

Current Price	$31.45
Prev Close	$30.97
Open	$30.80
Dividend Yield	0.00%
50-Day Moving Average	$26.86
Beta	1.10
Avg. Volume	2.86M
PE Ratio	37.29

52-Week High	$71.37
52-Week Low	$17.15
Market Capitalization	$5.52B
EPS (Annual)	$0.9849
Price to Book	6.17
Revenue Per Employee	$732,798.86

Feed

News

Sentiment

Earnings

Fundamentals

Info

DOCS Fundamentals